The roles of protein-tyrosine phosphatases (PTPs) in processes such as cell growth and adhesion are poorly understood. To explore the ability of specific PTPs to regulate cell signaling pathways initiated by stimulation of growth factor receptors, we expressed the receptor-like PTP, PTP␣, in A431 epidermoid carcinoma cells. These cells express high levels of the epidermal growth factor (EGF) receptor and proliferate in response to the autocrine production of transforming growth factor-␣. Conversely, EGF stimulation of A431 cells in vitro leads to growth inhibition and triggers the rapid detachment of these cells from the substratum. Although PTP␣ expression did not alter the growth characteristics of either unstimulated or EGF-stimulated cells, this phosphatase was associated with increased cell-substratum adhesion. Furthermore, PTP␣-expressing A431 cells were strikingly resistant to EGF-induced cell rounding. Overexpression of PTP␣ in A431 cells was associated with the dephosphorylation/activation of specific Src family kinases, suggesting a potential mechanism for the observed alteration in A431 cell-substratum adhesion. Src kinase activation was dependent on the D1 catalytic subunit of PTP␣, and there was evidence of association between PTP␣ and Src kinase(s). PTP␣ expression also led to increased association of Src kinase with the integrin-associated focal adhesion kinase, pp125
Reversible protein phosphorylation is a widely employed mechanism for regulating enzyme activity, assembly, and localization of protein complexes and gene transcription within eukaryotic cells (1, 2) . Protein phosphorylation also controls cytoskeleton organization during cell adhesion to extracellular matrix (ECM) 1 or to other cells during processes such as morphogenesis, cell migration, differentiation, and metastases (3) . Indeed, similar to growth factor receptor-mediated signal transduction, engagement of cell adhesion molecules is followed by the rapid activation of specific protein tyrosine kinases and the ensuing assembly of multimeric protein complexes at sites of cell adhesion (4) . Moreover, many of the signal transduction molecules activated or phosphorylated in response to ligand binding to growth factor receptors are also regulated by cell adhesion (5, 6) .
Due to their ability to regulate protein phosphotyrosine levels, PTPs are undoubtedly essential to such processes as proliferation, differentiation, and cell adhesion (7) (8) (9) . However, the roles of specific PTPs in the regulation of growth factor receptor initiated signal transduction events and cell adhesion remain poorly understood. In this study, we have evaluated the ability of the receptor-like phosphatase PTP␣ to regulate EGFreceptor-dependent cell signaling processes in the human epidermoid carcinoma cell line A431. Structurally, the widely expressed PTP␣ is composed of a heavily N-and O-glycosylated 123-or 132-residue alternatively spliced extracellular domain, a transmembrane region, and two tandem cytoplasmic phosphatase domains, as is characteristic of the majority of receptor-like PTPs (10 -13) .
A431 cells have been well characterized with respect to EGFdependent signal transduction. These cells express high levels of the EGF receptor on their surface (0.5-3.0 ϫ 10 6 /cell) (14) , and proliferate in response to autocrine production of transforming growth factor ␣ (15) . Although EGF enhances the growth of A431 cell-derived tumors in nude mice, when grown as a monolayer in culture, these cells, similar to squamous cell carcinoma cell lines overexpressing EGF receptors, are inhibited by high concentrations of EGF (14, 16 -21) . In addition, EGF stimulation of A431 cells causes dramatic change in cell morphology, including extensive membrane ruffling, filipodia extension, and changes in cytoskeletal organization and cell adhesion. These processes culminate in the rounding-up and retraction of these cells from the substratum (22) (23) (24) . Thus, A431 cells have proven invaluable to studies of cell growth, differentiation, and cell adhesion as regulated by receptor tyrosine kinase activity.
We found that PTP␣ expression in A431 cells led to a PTP␣ D1-dependent increase in cell-substratum adhesion and inhibited EGF-induced cell rounding and lift-off. This PTP␣-dependent phenotype was not restricted to EGF stimulated A431 cells, as PTP␣ expression in BHK-IR cells also led to resistance of these cells to insulin-induced cell rounding and detachment from the substratum. These results suggest that PTP␣ might be capable of regulating the activities of molecules involved in cell-substratum adhesion. In keeping with this hypothesis, we found that in A431 cells PTP␣ could be co-immunoprecipitated with Src kinase(s). PTP␣ expression was also associated with the dephosphorylation and/or activation of specific Src kinases. Moreover, Src kinases immunoprecipitated from PTP␣-expressing A431 cells were associated with elevated levels of focal adhesion kinase (FAK), a molecule activated by stimuli such as integrin-dependent cell adhesion to the substratum, v-src transformation, and growth factor or neuropeptide stimulation (reviewed in Ref. 25) . PTP␣ expression was also associated with an increase in the tyrosine phosphorylation of paxillin, a protein localized to focal adhesions and a putative substrate of FAK and/or Src kinases (26 -28) . Paxillin obtained from PTP␣-expressing cells was complexed with increased levels of Csk, suggesting a possible feedback loop in the regulation of Src activity in these cells and supporting previous observations linking the activation of Src kinases with changes in the intracellular localization of Csk (29 -33) . The dephosphorylation of Src kinases, together with the observed PTP␣ D1-dependent changes in cell adhesion and the tyrosine phosphorylation and association of FAK and paxillin with Src and Csk kinases, support the hypothesis that PTP␣ may be involved in the regulation of cell-substratum adhesion.
EXPERIMENTAL PROCEDURES
Cells and Plasmids-A431 cells were obtained from the American Type Culture Collection and were grown in Dulbecco's modified Eagle's medium containing 10% fetal calf serum, antibiotics, and 50 M ␤-mercaptoethanol. The PTP␣ cDNA was obtained from a human HepG2 cell line cDNA library (Stratagene) as described previously (10) . The wild type and catalytically inactive forms of PTP␣ (containing a cysteine-toalanine mutation at residue 433 within the first catalytic domain, D1 C433A) were subcloned into the eukaryotic expression vector pBCMGNeo. This vector contains the cytomegalovirus immediate-early gene promoter and 79% of the bovine papilloma virus genome, allowing episomal replication of transfected plasmids (34) . Plasmids were introduced into A431 cells by electroporation, and G418 resistant clones were selected. The BHK cell line overexpressing the human insulin receptor (BHK-IR) (35) was maintained at 37°C under 5% CO 2 in Dulbecco's modified Eagle's medium containing 4.5 g/liter glucose, 10% fetal calf serum, 2 mM L-glutamine, 1 M methotrexate, and penicillin/ streptomycin. This cell line was used to establish stable BHK-IR cell lines overexpressing PTP␣ in a functionally dependent way as described previously (36) . BHK-IR/PTP␣ cells were maintained in complete medium in the presence of 100 nM insulin.
Antibodies-PTP␣-specific antibodies were produced by immunization of New Zealand White rabbits with recombinant PTP␣ cytoplasmic domain containing residues 167-793 (PTP␣-2) or with N-terminal cysteine-linked keyhole limpet hemocyanin conjugated synthetic peptides (37) , corresponding to amino acids 20 -60 within the extracellular domain of PTP␣ (PTP␣-ext), or residues 512-558, corresponding to the region separating the two catalytic domains (PTP␣-1). Antibodies were affinity purified on thiol-Sepharose peptide or CNBr-Sepharose recombinant PTP␣ specific affinity columns. The anti-Src mAb 327 (provided by J. Brugge, ARIAD Pharmaceuticals), anti-Fyn mAb (provided by R. Perlmutter, University of Washington, Seattle, WA), anti-Yes antiserum (from J. Bolen, Bristol-Myers Squibb Pharmaceutical Research Institute, Princeton, NJ), and anti-Csk antiserum (from J. Cooper and B. W. Howell, Fred Hutchinson Cancer Research Center) were used to immunoprecipitate each kinase. The antibody SRC2 (Santa Cruz Biotechnology), specific for the C-terminal peptide sequence 509 -533 of Src and the conserved sequences of Fyn and Yes, was also used to immunoprecipitate and immunoblot Src, Fyn, and Yes. Antibodies against phosphotyrosine (4G10), paxillin, FAK, and Src (GD11) were obtained from Upstate Biotechnology Inc. and Transduction Laboratories. AntiLyn kinase antibodies were obtained from Santa Cruz Biotechnology Inc.
A431 Cell Lysis-A431 cells were lysed on ice for 30 min in buffer containing 1% Nonidet P-40, 10% glycerol, 50 mM NaCl, 50 mM Tris, pH 7.5, 2 mM EDTA, 1 mM sodium orthovanadate, 10 mM sodium fluoride, 1 mM phenylmethylsulfonyl fluoride, 1 mM soybean trypsin inhibitor, and 100 M leupeptin. Insoluble cellular debris was removed by ultracentrifugation at 30,000 ϫ g for 30 min. Protein concentrations were estimated with the bicinchoninic acid assay (Pierce).
Kinase Assays-Src kinase activity from transfected A431 clones was assessed by autokinase and enolase assays. Src kinase was immunoprecipitated from 500 g of cell lysate with 1 g of mAb 327. Immune complexes were collected with 75 l of a 30% slurry of rabbit anti-mouse IgG preabsorbed protein A-Sepharose. Beads were washed in cell lysis buffer, radioimmune precipitation buffer (lysis buffer containing 1% Nonidet P-40, 0.5% deoxycholic acid, and 0.1% SDS), and then kinase buffer (100 mM PIPES, pH 7.0, 5 mM MnCl 2 , and 10 M vanadate) before resuspension in kinase buffer containing 25 M ATP and 10 Ci [␥-
32 P]ATP (3000 Ci/mmole) with or without 10 g of acid-denatured enolase. Kinase assays were performed at 25°C for 15 min before termination by addition of 2ϫ Laemmli buffer. 50% of each immunoprecipitate was immunoblotted with anti-Src antiserum (GD11) to ensure that equal quantities of Src were used in each assay.
Bacterial Expression-Regions corresponding to the entire cytoplasmic domain of PTP␣ (PTP␣-D1ϩD2, amino acids 167-793), the first catalytic domain (PTP␣-D1, amino acids 167-555), and the C-terminal phosphatase domain (PTP␣-D2, amino acids 510 -793), were polymerase chain reaction-amplified with Vent DNA polymerase (New England Biolabs). The cDNA sequence of each PTP␣ fragment was confirmed by DNA sequencing before subcloning into pGex 2T-tag, a modified pGex 2T plasmid, containing an expanded polylinker and sequence encoding the 10-residue hemagglutinin epitope tag derived from influenza virus (38) . Thrombin cleavage of glutathione S-transferase (GST) fusion proteins generates proteins containing the hemagglutinin epitope at the N terminus. Luria broth cultures (500 ml) of UT5600 bacteria (New England Biolabs) containing the various pGex plasmids were grown to absorbance 0.6 -0.9 at 37°C. Cells were then shifted to 26°C and induced overnight with 100 M isopropyl-1-thio-␤-D-galactopyranoside. Bacteria were sedimented and lysed by sonication in buffer composed of 50 mM Tris, pH 7.5, 150 mM NaCl, 5 mM ␤-mercaptoethanol and 1 mM phenylmethylsulfonyl fluoride. Triton X-100 was then added to 1% final concentration, and cellular debris were removed by ultracentrifugation at 30,000 ϫ g. The supernatant was removed and incubated with 1 ml of a 50% slurry of glutathione-Sepharose (Amersham Pharmacia Biotech) for 1 h. The beads were thoroughly washed before cleavage in 1 ml of buffer containing 50 mM Tris, pH 8.0, 2.5 mM CaCl 2 , 150 mM NaCl, 10 mM ␤-mercaptoethanol, and 50 l of thrombin (400 g/ml). Glycerol was added to a final concentration of 15% before storage at Ϫ80°C.
Malachite Green Phosphatase Assay-Phosphatase activity was determined using the malachite green microtiter plate (MGMP) phosphatase assay to detect the release of phosphate from phosphotyrosinecontaining synthetic peptides as described previously (38) . Briefly, recombinant PTP␣ or PTP␣ immunoprecipitated directly from A431 cell lysates was incubated with phosphopeptides in buffer containing 25 mM MES, pH 6.0, and 0.1 mM ␤-mercaptoethanol. Enzyme reactions were carried out in half-volume microtiter plates (Costar) in a final volume of 25 l for the indicated times. Phosphatase reactions were terminated and free phosphate detected by addition of 100 l of malachite green solution to each well. Changes in absorbance at 620 nm of each well were measured in an enzyme-linked immunosorbent assay plate reader and phosphate release was determined by comparison to a standard curve (38) . Phosphopeptides Src-527 YTSTEPQpYQPGENL and CSF-1 receptor 708 YIHLEKKpYVRRDSG were synthesized as described previously (38, 39) . The activity of PTP␣-D2 toward para-nitrophenylphosphate (40) was detected using the MGMP assay as above.
A431/EGF Growth Inhibition Assay-Passage number 10 or less control vector alone-transfected and PTP␣-overexpressing A431 cell lines were plated at 10 4 cells/well in quadruplicate in 96-well plates. EGF was added, and cell proliferation was determined 4 days later by WST-1 (4-[3-(4-iodophenyl)-2-(4-nitrophenyl)-2H-5-tetrazolio]-1,3-benzene disulfonate) assay (Boehringer Mannheim).
BHK-IR and BHK-IR/PTP␣ Growth Curves-The effect of PTP␣ expression on the growth characteristics of BHK-IR cells was analyzed by comparing growth curves obtained with and without insulin as described previously (36) . In short, five 6-well plates were plated at 2 ϫ 10 4 cells/well. After 24 h, the number of adherent cells per well was determined in one plate (day 0). Three wells in each of the remaining four plates then received insulin at a final concentration of 100 nM (ϩ insulin) with the other three wells serving as controls (Ϫ insulin). The number of adherent cells was determined in one plate after a further 24 h of incubation (day 1), whereas the remaining plates were washed thoroughly three times to remove nonadherent cells. Fresh medium with and without insulin was added. This procedure was repeated every 24 h for the next three days. Similar results were obtained in two independent experiments.
Cell-Substratum Adhesion Assay-During routine passaging of PTP␣-overexpressing A431 clones, we observed that these cells were resistant to removal from the substratum by low concentrations of trypsin (0.05%). To quantitate this characteristic, an adhesion assay was developed to assess cell-substratum adhesion. Cells containing vector alone, PTP␣, or PTP␣ (D1 C433A) were plated in 96-well flatbottom plates in quadruplicate at 10 4 cells/well. Cells were allowed to adhere and spread in serum-containing medium to 75-85% confluency (1-2 days). Medium was then carefully removed so as not to disturb the cell monolayer, and the cells were gently washed 3-5 times with 100 l of Ca 2ϩ -and Mg 2ϩ -free PBS/well/wash over a period of 20 -30 min. During this treatment, control cells rounded and lifted off the substratum in a manner that was dependent on the number and duration of the PBS washes. To be able to discern the lower adherence of control and PTP␣ (D1 C433A)-transfected A431 cells, the number and duration of PBS washes was reduced. Wash solutions were then discarded, and 100 l of culture medium was added to each well. One hour later, 25 l of 3-(4,5-dimethyl thiazol-2-yl)-2,5-diphenyl tetrazolium bromide (5 mg/ ml) was added, and the cells remaining in each well were stained for 2.5 h. Medium was then carefully removed, 100 l of Me 2 SO was added to each well to dissolve the precipitated 3-(4,5-dimethyl thiazol-2-yl)-2,5-diphenyl tetrazolium bromide crystals, and the absorbance at 550 nm was determined using an enzyme-linked immunosorbent assay plate reader. The 3-(4,5-dimethyl thiazol-2-yl)-2,5-diphenyl tetrazolium bromide assay allowed linear detection of between 1000 and 70,000 cells/well. The absorbance of each well was compared with untreated wells to determine the percentage of cells removed by each washing protocol. For each cell line, the percentage difference in absorbance was found to be equivalent to the percentage of cells removed. To analyze adherence changes in response to agents known to alter cell-substratum adhesion, EGF (100 ng/ml), pervanadate (100 M vanadate, 2 mM H 2 O 2 ), and EDTA (10 mM) were added to the PBS washes, and the cells were treated as above.
Peptide Binding Assay-Lysates from A431 cells containing vector alone or from PTP␣-expressing or PTP␣ (D1 C433A)-expressing cells were incubated for 1 h with Src Tyr 527 phosphopeptide immobilized on CNBr-activated Sepharose. Beads were thoroughly washed in cell lysis buffer before resuspension in Laemmli buffer. Src family kinases precipitated by the beads were separated by 10% SDS-PAGE, transferred to Duralose membrane (Stratagene) and immunoblotted with SRC2 antisera or the Src-specific antibody (GD11). Immobilized nonphosphorylated Src Tyr 527 peptide was used as a control. Blots were developed using horseradish peroxidase-linked goat anti-rabbit or goat antimouse antiserum and the ECL system (Amersham). A431 cells normally express relatively low levels of endogenous PTP␣ (Fig. 1A) . PTP␣ expression was determined by immunoblot analysis of A431 total cell lysates with polyclonal anti-peptide antibodies (anti-PTP␣-1) (Fig. 1A) or with antirecombinant PTP␣-specific antibodies (anti-PTP␣-2) (data not shown). Both of these antibodies recognized proteins of approximately 130 -150, 100, 85, and 68 kDa. N-and O-glycosylation of the predicted 85-kDa PTP␣ polypeptide chain results in a mature protein of between 130 and 150 kDa (11) . A 100-kDa form of PTP␣, observed in immunoblots of lysates derived from PTP␣-expressing cells (Fig. 1A) , was also immunoprecipitated from these lysates with antibodies specific for the extracellular region of PTP␣ (Fig. 1B) and likely corresponds to an N-glycosylated precursor of the larger form. This is in agreement with Daum et al. (11) , who reported that antibodies against baculovirus-expressed PTP␣ recognized a glycosylation-dependent epitope in the extracellular domain of PTP␣. The anti-PTP␣-extracellular domain antibodies used in our study were generated against residues 20 -60 of the extracellular domain, a region containing multiple potential N-and O-glycosylated residues. Thus, the PTP-extracellular domain antiserum likely recognized an incompletely glycosylated PTP␣ species. This antibody, however, bound to the surface of PTP␣-overexpressing cells with little or no binding observed to vector alone transfected control cells, demonstrating PTP␣ cell-surface expression in the transfected clones (data not shown).
RESULTS

Expression of PTP␣ in A431 Cells
A431 and BHK-1R Cells Expressing PTP␣ Are Resistant to the Cell-rounding and Adhesion-disrupting Effects of Growth
Factors-To assess whether PTP␣ expression would alter the EGF-induced growth inhibition response of A431 cells, we treated vector alone control cells and PTP␣-transfected clones with various concentrations of EGF. Cell numbers were then determined by WST-1 assay (as described under "Experimental Procedures"). Maximal inhibition of vector control transfected cell growth was observed at EGF concentrations between 5-10 ng/ml ( Fig. 2A) . The response of two PTP␣-expressing A431 clones (PTP␣-1 and PTP␣-2) to EGF are shown in Fig. 2A . The expression of PTP␣ in A431 cells was unable to rescue these cells from the growth inhibitory effects of EGF. However, a dramatic change in cell morphology was evident following exposure of A431 cells to EGF in serum-free conditions. Whereas EGF caused control A431 cells to round-up and lift-off the substratum within 5-10 min (Fig. 2 , B and C, rounded phasebright cells in A431-Ctr 1 and A431-Ctr 2 EGF-treated panels) clones expressing PTP␣ remained adherent and spread following exposure to EGF (Fig. 2 , B and C, clones PTP␣-1 and PTP␣-3). This phenotype was observed in all of the PTP␣-expressing clones and was dependent on the catalytic activity of PTP␣ D1 (data not shown).
A previously established BHK-IR cell line (35) responds to insulin stimulation with growth inhibition, cell rounding, and detachment from the substratum of cell culture dishes (36) . These cells round up quickly after addition of insulin, with detachment being detectable as early as 1 h after the addition of insulin. The optimal insulin concentration required to bring about this effect was approximately 100 nM, with the halfmaximal effect being observed at a concentration of approximately 1 nM. In contrast, stable BHK-IR cell lines overexpressing PTP␣ failed to round up and remained attached to the substratum (data not shown). Thus, in these two different cell model systems, PTP␣ expression was capable of inhibiting adhesion-disrupting effects induced by the activation of two distinct receptor tyrosine kinases.
PTP␣ Expression Prevents Insulin-induced Growth Inhibition of BHK-IR Cells-
We have previously shown that insulin completely abolishes the growth of BHK-IR cells while having no effect on the parental BHK cell line (36) . Based on these phenotypic changes, it was possible to introduce a novel selection procedure that allowed establishment of stable BHK-IR cell lines expressing PTPs in a functionally dependent manner. To further assess the effect of PTP␣ expression on insulininduced growth inhibition, we compared the growth of BHK-IR/PTP␣ cells with the BHK-IR cell line with and without insulin. As shown in Fig. 3 and in contrast to the effect of PTP␣ expression in A431 cells, this PTP rendered the BHK-IR cell line partially resistant to the growth inhibitory effect of insulin.
Increased Cell-Substratum Adhesion of PTP␣-expressing A431 Cells-A431 cells overexpressing PTP␣, grown in the absence of EGF, were also more adherent to the substratum than control vector alone transfected A431 cells. This characteristic was quantified using an adhesion assay based on measuring the resistance of PTP␣-expressing cells to rounding-up and release from the substratum following incubation in PBS (described under "Experimental Procedures"). Although greater than 80% of control A431 cells were removed from the substratum after four gentle washes in PBS (e.g. Ctr (untreated) A 550 ϳ 2.3, Ctr (PBS-washed) A 550 ϳ 0.3), only 30% of cells expressing PTP␣ were removed (e.g. PTP␣-1 (untreated) A 550 ϳ 2.2, PTP␣-1 (PBS-washed) A 550 ϳ 1.4) (Fig. 4A) . Results of the adhesion assay shown in Fig. 4A were obtained with A431 clone PTP␣-1, whereas those results shown in Fig. 2B were obtained with clones PTP␣-1 and PTP␣-3. To determine whether this characteristic was dependent on the catalytic activity of PTP␣, or possibly due to a PTP␣ extracellular domain-ECM interaction, we also evaluated the adhesion phenotype of PTP␣ (D1 C433A)-expressing cells. To be able to assess the differences in adhesion of control vector and PTP␣ (D1 C433A)-transfected cells, the number and duration of the PBS washes was reduced as compared with Fig. 4A . Although PTP␣ (D1 C433A) protein levels were similar to those of cells transfected with wild type PTP␣ (Fig. 1, A and B) , these cells were removed from the substratum more readily than control vector-alone transfected cells (Fig. 4B ) (e.g. Ctr (untreated) A 550 ϳ 2.3, Ctr (PBSwashed) A 550 ϳ 2.3, PTP␣-D1 C433A (untreated) A 550 ϳ 2.4, PTP␣-D1 C433A (PBS-washed) A 550 ϳ 1.8). The results indicated that the catalytic activity of PTP␣ was essential to the increased cell-substratum adhesion phenotype of the PTP␣-expressing A431 clones. Consistent with this conclusion, addition of the PTP inhibitor pervanadate to the PBS washes eliminated the adhesion differences between PTP␣-expressing and untreated control A431 cells (Fig. 4A) . Pervanadate treatment also reduced the adhesion of control and PTP␣ (D1 C433A)-expressing cells, hinting at a general role for PTPs in the maintenance of A431 cell-substratum adhesion (Fig. 4 , A and The effect of EGF stimulation on A431 cell-substratum adhesion was also evaluated using this assay. As anticipated and reflected by the cell rounding and detachment depicted in Fig.  2B , C, EGF stimulation profoundly reduced cell-substratum adhesion of control A431 cells in these adhesion assays. However, whereas almost 100% of vector control A431 cells were released from the substratum by exposure to EGF in serumfree conditions (e.g. Ctr (untreated) A 550 ϳ 2.3, Ctr (EGFtreated) A 550 ϳ 0.004), approximately 40% of PTP␣-transfected cells remained adherent and spread (e.g. PTP␣-1 (untreated) A 550 ϳ 2.2, PTP␣-1 (EGF-treated) A 550 ϳ 0.8) (Figs. 2, B and C, and 4A). In contrast, PTP␣ (D1 C433A)-expressing cells appeared more sensitive to the adhesion-disrupting actions of EGF than were vector control-transfected cells (e.g. Ctr (untreated) A 550 ϳ 2.5, Ctr (EGF-treated) A 550 ϳ 1.1, PTP␣-D1 C433A (untreated) A 550 ϳ 2.4, PTP␣-D1 C433A (EGF-treated) A 550 ϳ 0.4) (Fig. 4B) .
The increase in adhesion may have been due to altered expression of ECM proteins by PTP␣-overexpressing cells. However, the transfer of control A431 cells to plates on which PTP␣-expressing cells had been previously grown did not alter the adherence characteristics of the transferred cells (data not shown). This suggested that the augmented adhesion of PTP␣-expressing cells was an intrinsic property and not simply a result of alterations in ECM composition.
Potential Substrates of PTP␣-To investigate the basis for both the resistance of PTP␣-expressing cells to the EGF induced cell rounding and lift-off, and the altered cell adhesion of unstimulated cells, total cell lysates were evaluated for changes in anti-phosphotyrosine antibody (4G10) immunoreactivity. Anti-phosphotyrosine immunoblots of total cell lysates from unstimulated control vector alone-, PTP␣-, or PTP␣ (D1 C433A)-transfected cells revealed reduced phosphotyrosine levels in proteins with molecular masses of 50 -65 kDa only in the PTP␣-expressing cells (Fig. 5A) . In contrast, other proteins with molecular masses of approximately 70 and 120 -130 kDa exhibited enhanced anti-phosphotyrosine immunoreactivity in these cells. As previously discussed and shown in Fig. 4A , differences in the adhesion of control and PTP␣-expressing cells were readily apparent in unstimulated cells. Moreover, because EGF stimulation led to dramatic increases in whole scale tyrosine phosphorylation that were indistinguishable between cell lines (data not shown), we focused on the identification of potential substrates of PTP␣ in unstimulated cells. In addition, we did not observe any alteration in the basal level of EGF receptor tyrosine phosphorylation in cells expressing PTP␣ (data not shown).
It was previously reported that expression of PTP␣ in Fischer rat embryo fibroblasts (41) and P19 cells (42) was associated with pp60 c-Src kinase activation. In rat embryo fibroblasts, PTP␣ expression was associated with cell transformation, whereas PTP␣ expression in P19 cells shifted the differentiation of these cells toward a neuronal cell phenotype (41, 42) . These studies did not specify whether PTP␣ expression had resulted in any general changes in cellular protein phosphotyrosine content or if only Src-specific alterations were observed. To determine whether the dephosphorylated 50 -65-kDa proteins in A431 cell lysates corresponded to Src kinase(s), we immunoprecipitated Src, Yes, Fyn, and Lyn and assessed their phosphotyrosine content. Reduced phosphotyrosine levels were observed for Src, Yes, and Fyn, whereas Lyn phosphotyrosine levels were unchanged (Fig. 5B) . Interestingly, dephosphorylation of Src and Yes was observed only in cells expressing wild type PTP␣, whereas Fyn phosphotyrosine content appeared to be reduced in PTP␣ (D1 C433A)-expressing cells. However, in contrast to the other Src family kinases, Fyn protein levels were strikingly reduced in cell lines overexpressing either PTP␣ or PTP␣ (D1 C433A) (Fig. 5C) . Thus, the reduction in Fyn anti-phosphotyrosine immunoreactivity is likely a result of reduced Fyn protein levels. The reduction in Fyn protein did not appear to be due to changes in the solubility of this protein, and was typical of all A431 clones expressing PTP␣ (data not shown).
PTP␣ Expression Results in Src Kinase
Activation-Src family kinases are both positively and negatively regulated by tyrosine phosphorylation (43, 44) . C-terminal phosphorylation leads to the inhibition of enzyme activity through a proposed intramolecular association of the N-terminal SH2 and SH3 domains with the C terminus (45) (46) (47) (48) (49) (50) (51) . In contrast, tyrosine phosphorylation within the catalytic domain increases enzyme activity (52) . To determine the effect of PTP␣ expression on Src kinase activity, we immunoprecipitated Src from two other A431 clones expressing PTP␣. These two clones contained equivalent levels of PTP␣ protein (Fig. 6A ) and possessed similar levels of PTP␣ specific activity against a phosphopeptide based on Src Tyr 527 protein sequence (Fig. 6B ). In addition, Src kinase immunoprecipitated from these cells contained lower phosphotyrosine levels than Src immunoprecipitated from control A431 cells (Fig. 7, A and B) . The relative activity of Src was determined by autokinase and enolase assays (Fig. 7, C and D) . Src kinase isolated from these PTP␣-expressing cells was approximately 3-fold more active than control A431 derived Src kinase (as determined by scintillation counting of enolase excised from bands shown in Fig. 7D Recombinant PTP␣ Phosphatase Activity-The ability of the various domains of PTP␣ to dephosphorylate Src Tyr 527 was also investigated in vitro using recombinant PTP␣ and synthetic phosphopeptide substrates. The entire cytoplasmic region of PTP␣ (PTP␣-D1ϩD2), the membrane-proximal catalytic domain (PTP␣-D1), and the second catalytic domain alone (PTP␣-D2) were expressed in bacteria as GST fusion proteins. Recombinant proteins were incubated with phosphopeptides corresponding to the C-terminal sequence of Src ( 527 YTSTEPQpYQPGENL) or peptides corresponding to sequences surrounding an autophosphorylation site in the CSF-1 receptor ( 708 YIHLEKKpYVRRDSG). Phosphate release was then determined using the MGMP assay (38) . PTP␣-D1ϩD2 and PTP␣-D1 catalyzed the dephosphorylation of the two phosphopeptide substrates, with both enzymes showing a preference for the Src Tyr 527 peptide (Fig. 8, A and B (Fig. 8C) . Thrombin-cleaved preparations from GST-alone lysates exhibited no detectable PTP activity in any of the PTP assays (data not shown). PTP␣-D2, like PTP␣-D1ϩD2 and PTP␣-D1, was more active toward the Src Tyr 527 phosphopeptide than the CSF-1 receptor Tyr 708 peptide. However, detection of PTP␣-D2 activity required approximately 100-fold more enzyme (approx. 1 g versus 10 ng) than those assays with fusion proteins containing domain-1. In keeping with the low activity of recombinant PTP␣-D2 toward Src Tyr 527 , immunoprecipitates of PTP␣ from A431 cell lysates derived from A431 cells expressing the PTP␣ C433A D1 mutant exhibited dramatically reduced activity as compared with immunoprecipitates of wt. PTP␣ (Fig. 8D) . Thus, whereas recombinant PTP␣-D2 displayed low but detectable activity in vitro, no domain-2-specific activity was detected in the context PTP␣ 2) . B, PTP␣ was immunoprecipitated from A431 cell lysates obtained from these cells using anti-peptide antibodies against residues 512-558 of the intercatalytic region of PTP␣ and PTP activity was assessed by measuring the dephosphorylation of Src Tyr 527 phosphopeptide using the MGMP assay. P i release was determined by absorbance measurement at 620 nm at the indicated times. of an inactive domain-1. However, this may have been a consequence of insufficient protein being obtained in the immunoprecipitation assay as compared with the recombinant PTP assay. The lack of detectable activity against the Src Tyr 527 phosphopeptide in PTP␣ (D1 C433A) immunoprecipitates and the PTP␣ D1-dependent reduction in both Src and Yes phosphotyrosine levels in transfected A431 cells (Fig. 5B) would be predicted to exhibit enhanced SH2 domain-mediated binding to phosphoproteins or phosphopeptides (50, 53) . Consistent with this model, we detected a marked increase in the amount of Src kinase precipitated from lysates derived from PTP␣-expressing cells by beads containing immobilized Src Tyr 527 phosphopeptide (Fig. 9, middle panel) . Beads containing immobilized non-phosphorylated Src Tyr 527 peptide did not retain Src kinase from any of the cell lysates (Fig. 9, right  panel) . Interestingly, SRC2 immunoblots of phosphopeptide immunoprecipitates revealed a band of approximately 62 kDa retained by Src Tyr 527 phosphopeptide-Sepharose (Fig. 9, left  panel) . Although an antibody able to specifically immunoblot Yes was not available, the SRC2 antibody immunoblot, and the reduction in phosphotyrosine content of Yes in anti-Yes immunoprecipitates (Fig. 5B) suggested that PTP␣ expression was accompanied by dephosphorylation of the C-terminal regulatory site of this kinase. The enhanced binding of Src kinases to Src Tyr 527 peptide beads, like the reduction in Src and Yes phosphotyrosine levels observed in Fig. 5, A and B, required PTP␣ D1, as Src Tyr 527 peptide beads incubated with lysates derived from PTP␣ (D1 C433A)-expressing cells retained similar levels of Src and Yes protein as control A431 cell derived lysates (Fig. 9, left and middle panels, lane 3) .
PTP␣ Co-immunoprecipitates with Src Kinase(s)-To further investigate the relationship between PTP␣ and Src kinases, we assessed whether these enzymes were associated within cells using co-precipitation studies. SRC2 antibody immunoprecipitates of Src, Yes, and Fyn from A431 cells expressing either PTP␣, or PTP␣ (D1 C433A), were able to co-immunoprecipitate PTP␣. Although Fig. 10 (right lanes) suggests reduced levels of PTP␣ co-immunoprecipitated with Src kinases in cells expressing PTP␣ (D1 C433A), this was not consistently observed. We also investigated whether PTP␣ co-immunoprecipitated with Csk, as PTP␣ Y579 and Y789 were phosphorylated by this kinase in vitro. 2 However, we were unable to co-immunoprecipitate PTP␣ and Csk from A431 cells (Fig. 10, right panel) . Antibodies directed against FAK, paxillin, or the ␤-1 integrin also failed to co-immunoprecipitate PTP␣ in these cells (data not shown). The stoichiometry of association between Src kinase(s) and PTP␣ may be low as detection of co-precipitating PTP␣ required immunoblotting with anti-recombinant PTP␣ antibodies (anti-PTP␣-2) and was not detected with anti-PTP␣ peptide antiserum (anti-PTP␣-1) (data not shown). Moreover, we have been unable to detect PTP␣ in SRC2 immunoprecipitates from transiently transfected HEK 293 cells overexpressing PTP␣. However, specific antibodies against Src (GD11) and Yes were also able to co-immunoprecipitate PTP␣ from A431 cells (data not shown). These antibodies, however, were less efficient at co-immunoprecipitating PTP␣ than the SRC2 antiserum.
To look for sites in PTP␣ that might mediate an association with Src, we investigated a membrane-proximal proline-rich motif (STNRKYPPLPVDKLE) in PTP␣ for its capacity to associate with various SH3 domains. Although this region bound to the SH3 domains of Src, Yes, Fyn, Lyn, and other SH3 domains in vitro, mutation of the two Pro residues in this sequence to Ala failed to prevent PTP␣ from co-precipitating with Src kinases. 3 Thus, the association between PTP␣ and Src FIG. 8 . PTP␣ bacterial expression and enzymatic activity. The entire cytoplasmic region of PTP␣ (PTP␣-D1ϩD2), the membrane-proximal catalytic domain (PTP␣-D1), and the second catalytic domain alone (PTP␣-D2) were expressed as GST fusion proteins, purified with glutathione-Sepharose and thrombin cleaved for in vitro analysis of enzyme activity. Enzymes corresponding to PTP␣-D1 ϩ D2 (A), PTP␣-D1 (B), and PTP␣-D2 (C) were assayed for activity against pnitrophenylphosphate (f) (for PTP␣-D2) or Src Tyr 527 (E) and CSF-1 Tyr 708 (q) phosphopeptides. Substrate dephosphorylation was assessed by measurement of liberated phosphate using the malachite green microtiter plate assay. P i was detected by spectrophotometer measurement at 620 nm and compared with a P i /malachite green standard curve. Control lysates expressing GST alone displayed no detectable PTP activity (data not shown). In D, PTP␣ was immunoprecipitated from cells transfected with either wt. PTP␣ or PTP␣ (D1-C433A) using anti-peptide antibodies against residues 512-558 of the intercatalytic region (anti-PTP␣-1). Dephosphorylation of Src Tyr 527 phosphopeptide by immunoprecipitated PTP␣ was then assessed as above. kinase(s) does not appear to be mediated exclusively via Src family SH3 domains. The structural basis for the observed PTP␣-Src association, which could be either direct or mediated via a linker molecule, requires further investigation.
Protein Phosphotyrosine Levels in PTP␣-expressing Cells-An interesting consequence of PTP␣ expression in A431 cells was the selective reduction of Src family kinase phosphotyrosine levels. Indeed, arguing for the specificity of PTP␣ for Src and Yes kinases, proteins of 70 and 110 -130 kDa exhibited an increase in anti-phosphotyrosine immunoreactivity in PTP␣-expressing cells (Fig. 11A) . Previous studies have demonstrated that v-Src, Tyr 527 F mutants of c-Src, and Src kinases activated within CskϪ/Ϫ mouse embryo fibroblasts induce the tyrosine phosphorylation of specific proteins (32, 43, 44) . Many of these Src family kinase substrates are localized and/or involved in the organization of the cytoskeleton. The changes in cell adhesion of PTP␣-expressing A431 cells therefore suggested this phosphatase might be involved in regulating Src kinase activity at focal adhesions.
Increased Src Kinase Association with FAK in PTP␣-expressing Cells-To establish whether the proteins displaying increased anti-phosphotyrosine immunoreactivity in PTP␣-expressing A431 cells were associated with Src kinase(s), Src, Yes, and Fyn were immunoprecipitated with SRC2 antiserum. Immunoblotting of these immunoprecipitates with anti-phosphotyrosine antibodies revealed proteins of 110 -130 and approximately 220 kDa co-immunoprecipitating with Src kinase(s) (Fig. 11B) . The activation of Src enhances the phosphorylation and activation of FAK, a 125-kDa kinase localized at focal adhesions and activated in response to integrindependent cell adhesion (32, 54 -57) . Others have reported the SH2 domain-dependent association of Src family kinases with FAK (58, 59) . To determine whether the 125-kDa phosphoprotein co-immunoprecipitating with Src kinase(s) was FAK, SRC2 immunoprecipitates were immunoblotted with anti-FAK antibodies. Increased quantities of FAK were observed in SRC2 immunoprecipitates from PTP␣-overexpressing cells (Fig.  11C) . In keeping with an enhanced association of Src kinase(s) with FAK, we observed a small but consistent increase (1.5-2-fold) in the level of FAK tyrosine phosphorylation in all A431 clones expressing PTP␣ (Fig. 11D) . In contrast, in cells expressing PTP␣ (D1 C433A), FAK phosphotyrosine levels were approximately 50% lower than control A431 cell-derived FAK as judged by densitometry (Fig. 11D and data not shown) . FAK protein levels were not altered by expression of either PTP␣ or PTP␣ (D1 C433A) (Fig. 11E) . Immunoblots of SRC2 immunoprecipitates also detected elevated levels of both p130 Cas and p120 Cbl co-immunoprecipitating with Src kinases in cells expressing PTP␣ (data not shown). Cas has been previously identified as being associated with Src kinases and is a target of Src phosphorylation (60 -62) . Moreover, p130 Cas is tyrosine phosphorylated in response to cell-substratum adhesion and associates with FAK (63, 64) . We have not determined the identity of the ϳ 200-kDa phosphoprotein co-immunoprecipitating with Src kinase(s) (Fig. 11B) ; however, p220 tensin is a likely candidate (65) .
Enhanced Paxillin Tyrosine Phosphorylation in PTP␣-expressing Cells-The protein(s) exhibiting the most dramatic increase in phosphotyrosine content in PTP␣-expressing cells was ϳ 70 kDa, and did not co-immunoprecipitate with Src kinase(s) (Fig. 11B and data not shown) . We hypothesized that this phosphoprotein(s) might include paxillin, a 68 -70-kDa protein previously shown to be a substrate of Src and/or FAK (25, 26) . We immunoprecipitated paxillin from control, PTP␣-expressing, and PTP␣ (D1 C433A)-expressing cells and immunoblotted these immunoprecipitates with anti-phosphotyrosine antibodies. As predicted, increased levels of anti-phosphotyrosine immunoreactivity were detected within paxillin obtained from PTP␣-overexpressing cells (Fig. 12A) . Paxillin protein levels were similar among the three cell lines shown ( ation was a feature of all A431 cell lines expressing wild type PTP␣.
Increased Csk/Paxillin Association within PTP␣-expressing Cells-Src kinase-dependent tyrosine phosphorylation of paxillin is thought to result in the recruitment of Csk to phosphorylated paxillin via an interaction between the Csk SH2 domain and phosphotyrosine residues in paxillin (29, 31) . Sabe et al. (29, 33) demonstrated that v-Crk expression led to a 3-4-fold activation of Src kinase, whereas expression of Csk blocked Crk-dependent transformation of 3Y1 cells. The authors suggested that v-Crk expression inhibited the ability of Csk to associate with paxillin at sites of Src kinase activity (33) , thereby preventing Csk from negatively regulating Src activity. Thus, Src kinase regulation may involve a balance between the activity and localization of Csk and the coordinated activities of specific tyrosine phosphatases. The activation of Src kinase(s) by PTPs could result from either the dephosphorylation of paxillin (preventing the mobilization of Csk to sites of Src activity) or by the dephosphorylation of the Src kinase(s) C termini. In the latter instance, the PTP␣-dependent Src kinase(s) phosphorylation of paxillin would be predicted to result in the recruitment of Csk to sites of Src activity. Consistent with this prediction, we observed that Csk immunoprecipitated from PTP␣-overexpressing cells was complexed with a heavily tyrosine-phosphorylated group of proteins of approximately 70 kDa (Fig. 12C ), which reacted with paxillin-specific antibodies (Fig. 12D) . In contrast, within cells expressing PTP␣ (D1 C433A), the relative amount of paxillin co-immunoprecipitating with Csk was reduced as compared with control cells.
DISCUSSION
Although PTP␣ expression led to similar morphological changes in A431 and BHK-IR cells (as indicated by resistance to growth factor-induced cell rounding and detachment from the substratum), there was a difference with respect to the effect this phosphatase on factor-induced growth inhibition. Thus, whereas EGF-mediated growth inhibition of A431 cells was unaffected by PTP␣, the response of BHK-IR cells to insulin was clearly attenuated by the expression of this phosphatase. As described previously, PTP␣ expression in BHK-IR cells led to a reduction of insulin-stimulated receptor autophosphorylation (36) . As emphasized before (36) , the expression of any protein capable of impeding or blocking a signaling step leading to the described growth factor-induced phenotypic changes (growth inhibition, cell rounding, and detachment) could potentially lead to the isolation of cell clones refractory to these effects. Indeed, the identification of such cell lines by functionally coupling the expression of the activated insulin receptor with the expression of specific phosphatases able to oppose insulin-mediated effects demonstrated the feasibility of such a selection strategy (36) . In view of the results herein, it is conceivable that PTP␣ expressed in BHK-IR cells, in addition to bringing about the dephosphorylation of the insulin receptor, was also acting on other cellular substrates. Indeed, in both the BHK-IR and A431 cells, PTP␣ may be regulating similar sets of substrates involved in the receptor tyrosine kinase-induced morphological changes. Prevention of insulin-mediated BHK-IR cell growth inhibition, on the other hand, may well require the dephosphorylation/inactivation of upstream signaling components, most likely the insulin receptor itself.
In contrast to the BHK-IR cell studies, there was no discernible effect of PTP␣ on A431 cell EGF receptor autophosphorylation (data not shown), or on the proliferation of these cells, either in the presence or absence of EGF. However, we have not excluded the possibility that PTP␣ is capable of dephosphorylating specific sites within the EGF receptor or of dephosphorylating specific pools of this receptor. The inability of PTP␣ to alter autocrine transforming growth factor ␣-dependent cell growth, however, suggested that PTP␣ may not directly regulate EGFR, or any post-EGFR signaling events required for mitogenesis. Interestingly, EGF stimulation of A431 cells strongly increased the phosphotyrosine content of PTP␣ raising the possibility that this phosphatase might be regulated by EGF signaling. 4 Precisely how PTP␣ increases A431 cell-substratum adhesion and interferes with the cell adhesion-disrupting effects of EGF is unclear. Others have demonstrated involvement of phospholipid-derived second messages, such as arachidonic acid, in the regulation of EGF-induced A431 cell rounding (66) . Although PTP␣ expression might have a role in the production of phospholipase-A2 metabolites, investigation of potential substrates of PTP␣ in A431 cells pointed toward Src family kinases. We found that PTP␣ expression resulted in the dephosphorylation of Src and Yes kinases, with a 2-3-fold increase in Src kinase activity. Fyn protein levels were reduced in lines expressing either wild type or catalytically inactive PTP␣. However, it was unlikely that the altered adhesion of transfected cells was due to the change in Fyn levels as this phenotype was restricted to wild type PTP␣-expressing cells. No changes in Lyn phosphotyrosine levels were observed. Further support for Src and Yes being specific substrates of PTP␣ was suggested by the increased phosphotyrosine content of specific Src substrates in PTP␣-expressing cells. Furthermore, and supporting a role for PTP␣ in the activation of Src family kinase(s) localized to focal adhesions, we observed increased association of Src kinase(s) with FAK, increased tyrosine phosphorylation of paxillin, and an increased amount of Csk associated with this latter phosphoprotein. These effects, which we hypothesize account for the adherence phenotype of PTP␣-expressing A431 cells, would appear to be at odds with the phenomenon of anchorage-independence brought about by v- Src or Src Y527F expression in fibroblasts (52) . However, enhanced tyrosine phosphorylation of Src substrates is seen during the adhesion of cells to the substratum (32) , as well as during integrin-dependent activation of Src in thrombin-stimulated platelets (67) . In addition, defects in SrcϪ/Ϫ fibroblast spreading on fibronectin and the activation of Src kinase during normal fibroblast cell spreading on fibronectin (68) , as well as studies showing a requirement for Hck and Fgr in integrindependent neutrophil cell adhesion (69) , indicate that Src kinase(s) likely play a critical role in integrin-dependent cell adhesion events. Studies of the role of Csk in the regulation of Src kinases lend additional support for a function of Src kinases at focal adhesions (30, 32, 70) . Howell and Cooper (30) demonstrated that the SH2 and SH3 domains of Csk were required for mobilization of Csk to sites of Src activity in cellular structures that resembled podosomes and that the re-localization of Csk required Src kinase activity. Thus, the localization of Src and Csk to focal adhesions may be regulated positively by dephosphorylation of Tyr 527 or negatively by Csk. Indeed, Kaplan et al. (71) found that introduction of Src Tyr 527 into cells caused a redistribution of Src from endosomes to focal adhesions, and also that the N-terminal 251 residues of Src were sufficient for the targeting the kinase to these structures. Intriguingly, this region of Src was also sufficient to enhance FAK tyrosine phosphorylation and to increase anti-phosphotyrosine staining of focal adhesions (68) . Thus, regulating the accessibility of the N-terminal SH3 and SH2 domains of Src kinases, perhaps through dephosphorylation of both Tyr 527 and Tyr 416 by a PTP such as PTP␣, may regulate cell adhesion structures in a way quite different than that observed with viral forms of Src in which dramatic elevation of kinase activity and Tyr 416 phosphorylation are accompanied by anchorage independence (44) .
In view of our ability to co-immunoprecipitate PTP␣ with anti-Src antibodies, it is tempting to speculate that PTP␣ is directly responsible for Src Tyr 527 dephosphorylation and hence for subsequent interactions of Src with other focal adhesion molecules. It remains to be determined which class of adhesion molecule is responsible for the observed PTP␣-dependent change in A431 cell-substratum adhesion and also whether PTP␣-dependent dephosphorylation of Src kinases represents the sole mechanism for this change. It would be of interest to investigate the effects of overexpressing either wild type or kinase-inactive forms of Csk, or specific mutants of Src, to further define the potential role of Src kinases in A431 cell-substratum adhesion.
Interestingly, studies of LFA-1/ICAM-3-dependent T-cell aggregation and Mac-1/CD45-dependent hematopoietic cell adhesion to stromal heparan sulfate have suggested a role for CD45 in integrin-dependent cell adhesion (72) (73) (74) . Indeed, macrophages derived from mice lacking CD45 revealed a defect in macrophage adhesion that may correlate with the deregulation of both Hck and Lyn (75) . In addition, the receptor-like phosphatase LAR has been localized to focal adhesions through its interaction with LIP-1, where it may play a role in focal adhesion turnover (76) . Although the affinity of integrin family receptors for ECM components or other ligands can be regulated in an "inside-out" manner (3), we have not determined whether PTP␣ activity regulates the affinity of integrin receptors. Our observation that PTP␣ expression results in inhibition of EGF-and insulin-induced cell rounding and detachment from the substratum (in A431 and BHK cells, respectively) and that it leads to the activation of Src kinase(s) in A431 cells with ensuing alterations in the interactions and phosphorylation states of various focal adhesion-associated molecules suggests a potential role for this phosphatase in the regulation of cellsubstratum adhesion.
